CD103(+) T Cells May Be a Useful Biomarker in Borrmann Type 4 Gastric Cancer

MLA

Takuya Mori, et al. CD103(+) T Cells May Be a Useful Biomarker in Borrmann Type 4 Gastric Cancer. May 2022. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....587c13f0de236ccc6e75a7ca85130520&authtype=sso&custid=ns315887.

APA

Takuya Mori, Hiroaki Tanaka, Sota Deguchi, Yuichiro Miki, Mami Yoshii, Tatsuro Tamura, Takahiro Toyokawa, Shigeru Lee, Kazuya Muguruma, & Masaichi Ohira. (2022). CD103(+) T Cells May Be a Useful Biomarker in Borrmann Type 4 Gastric Cancer.

Chicago

Takuya Mori, Hiroaki Tanaka, Sota Deguchi, Yuichiro Miki, Mami Yoshii, Tatsuro Tamura, Takahiro Toyokawa, Shigeru Lee, Kazuya Muguruma, and Masaichi Ohira. 2022. “CD103(+) T Cells May Be a Useful Biomarker in Borrmann Type 4 Gastric Cancer,” May. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....587c13f0de236ccc6e75a7ca85130520&authtype=sso&custid=ns315887.